Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...

DBV Technologies (DBVT) announced that in a written responses only to the company’s Type D IND meeting request, the FDA agreed with the ...

According to the FDA’s public database, since the start of this year, the agency has issued only two de novo medical device ...

HHS’s top leadership is coming together after the Senate on Tuesday confirmed Drs. Jay Bhattacharya to lead the NIH and Marty ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

Humacyte, Inc.'s stock fell 25% amid $50M fundraising and safety concerns on FDA-approved Symvess. Click for this updated ...

The state Department of Consumer Protection apologized Friday for conducting what appeared to be a retaliatory inspection at ...

After a cannabis cultivator criticized CT's recreational marijuana testing protocols, the Department of Consumer Protection ...

President Donald Trump announced new auto tariffs as the controversy surrounding the Signal chat leak continues and his ...

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

On this "Face the Nation with Margaret Brennan" broadcast, National Security Adviser Mike Waltz and Rep. Rand Paul join ...

Apathy about shots, diseases like flu may be just as big a threat to public health efforts as vaccine mistrust.